ashg logo  

Media Contact:
Nalini Padmanabhan

ASHG Communications Manager

301.634.7346

press@ashg.org

 

For Immediate Release

Friday, September 18, 2015

12:00 pm U.S. Pacific Time (UTC-05:00)

 

 

ASHG 2015 Tipsheet: Cancer Genetics

 

WHEN: Tuesday through Saturday, Oct. 6-10, 2015


WHERE: American Society of Human Genetics 2015 Annual Meeting

Baltimore Convention Center, 1 West Pratt Street, Baltimore, MD 21201


WHAT: Invited and platform (oral) sessions and other presentations of the latest cancer genetics research:


Wednesday, Oct. 7, 9:50-10:10 am, Hall F
Plenary Presentation: Massively parallel experimental analysis of missense mutations in BRCA1 for interpreting clinical variants of uncertain significance
L. M. Starita, University of Washington

 

Wednesday, Oct. 7, 11:00 am-1:00 pm, Room 307
Invited Session: Cancer genetics in the genomics era
Moderators: Daniel C. Koboldt, Washington University in St. Louis; and Adam S. Kibel, Brigham and Women’s Hospital

 

Wednesday, Oct. 7, 2:30-4:30 pm, Ballroom I
Platform Session: Update on breast and prostate cancer genetics
Moderator(s): Jeffrey C. Barrett, Wellcome Trust Sanger Institute; and Mark J. Daly, Massachusetts General Hospital

 

Wednesday, Oct. 7, 2:30-4:30 pm, Ballroom III
Platform Session: Switching on to regulatory variation

Moderator(s): Gosia Trynka, Sanger Institute; and Yang Li, Stanford University

Thursday, Oct. 8, 2:30-4:30 pm, Room 307
Platform Session: Hereditary cancer genes: Old and new
Moderator(s): Angela Brooks-Wilson, Canada’s Michael Smith Genome Science Center; and Douglas Stewart, National Cancer Institute

 

Thursday, Oct. 8, 5:45-6:00 pm, Ballroom III
Platform Presentation: Deep genetic connection between cancer and developmental diseases
H. Qi, Columbia University, et al

 

Thursday, Oct. 8, 5:45-6:00 pm, Room 318/321
Platform Presentation: A novel (epi)genotype-specific and histotype-targeted tumor surveillance protocol in Beckwith-Wiedemann Syndrome based on cancer data meta-analysis
A. Mussa, University of Torino, et al

 

Thursday, Oct. 8, 6:30-6:45 pm, Room 316
Platform Presentation: Subclonal hierarchy inference from somatic mutations: Automatic reconstruction of cancer evolutionary trees from multi-region next generation sequencing
N. Niknafs, Johns Hopkins University, et al

 

Friday, Oct. 9, 2:15-4:15 pm, Room 318/321
Platform Session: Cancer genetic mechanisms
Moderator(s): Marc Greenblatt, University of Vermont; and Raju Kucherlapati, Brigham and Women’s Hospital

 

Friday, Oct. 9, 2:15-2:30 pm, Hilton Ballroom 1
Platform Presentation: Towards personalized cellular adoptive immunotherapy targeting tumor specific neo-antigens in microsatellite unstable colorectal cancers
P. Maby, Rouen University, et al

 

Friday, Oct. 9, 3:00-3:15 pm, Ballroom III
Platform Presentation: Assessing the clinical validity of genes implicated in hereditary pheochromocytoma/paraganglioma and pancreatic cancer using the ClinGen framework
R. Ghosh, Baylor College of Medicine, et al

 

Friday, Oct. 9, 3:00-3:15 pm, Hilton Ballroom 4
Platform Presentation: The return of whole exome sequencing results in a pediatric cancer setting: What is being said?
S. Scollon, Baylor College of Medicine, et al

 

Friday, Oct. 9, 4:30-6:30 pm, Ballroom I

Platform Session: Changing landscape of genomic testing

Saturday, Oct. 10, 10:30 am-12:30 pm, Room 316
Platform Session: Precision cancer sequencing
Moderator(s): Dayna Oschwald, New York Genome Center; and David Wheeler, Baylor College of Medicine

 

Saturday, Oct. 10, 1:45-3:45 pm, Hall F
Invited Session: Integrating genomes and transcriptomes to understand human disease
Moderators: Michael J. Clark, Personalis; and Tuuli Lappalainen, New York Genome Center

  • 1:45-2:15 pm: Correlative power of DNA to RNA in cancer genomics

    E. Mardis, Washington University in St. Louis

  • 2:45-3:15 pm: DNA and RNA integrated analysis in cancer and other disease

    D. Hayes, UNC Chapel Hill

Saturday, Oct. 10, 2:15-2:45 pm, Room 318/321
Invited Presentation: Fruit fly/mouse: Molecular genetics of tumor suppressor genes and oncogenes
D. Pan, Johns Hopkins University

 

Ongoing: Posters Open for Viewing, Exhibit Hall

Cancer Genetics, Posters 2567-2794
Health Services Research, Posters 2242-2262

 

* * *

 

About the American Society of Human Genetics (ASHG)

Founded in 1948, the American Society of Human Genetics is the primary professional membership organization for human genetics specialists worldwide. Its nearly 8,000 members include researchers, academicians, clinicians, laboratory practice professionals, genetic counselors, nurses, and others with an interest in human genetics. The Society serves scientists, health professionals, and the public by providing forums to: (1) share research results through the ASHG Annual Meeting and in The American Journal of Human Genetics; (2) advance genetic research by advocating for research support; (3) educate current and future genetics professionals, health care providers, advocates, policymakers, educators, students, and the public about all aspects of human genetics; and (4) promote genetic services and support responsible social and scientific policies. For more information, visit: http://www.ashg.org.

 

9650 Rockville Pike | Bethesda, MD 20814 | 301.634.7300 | society@ashg.org | www.ashg.org

Connect with ASHG on Twitter (@GeneticsSociety) | Facebook | LinkedIn